Hong Kong stock market anomaly | Holey Pharmaceuticals-B (02595.HK) surged more than 6% at the end of the day. The clinical research results of two investigational new drugs will be presented at the 2026 ASCO Annual Meeting.

According to the Securities Times APP, Junfang Pharmaceuticals-B (02595.HK) surged over 6% in the final trading session. As of the time of this report, it rose by 6.26% to 34.28 Hong Kong dollars, with a turnover of 44.4851 million Hong Kong dollars.